These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16217258)

  • 1. Will the next generation of "safer" cigarettes be safer?
    Warner KE
    J Pediatr Hematol Oncol; 2005 Oct; 27(10):543-50. PubMed ID: 16217258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.
    Thun MJ; Burns DM
    Tob Control; 2001; 10 Suppl 1(Suppl 1):i4-11. PubMed ID: 11740038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT; Abrams DB
    BMC Public Health; 2016 May; 16():432. PubMed ID: 27221096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco harm reduction: promise and perils.
    Warner KE
    Nicotine Tob Res; 2002; 4 Suppl 2():S61-71. PubMed ID: 12580158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smokers' beliefs about "Light" and "Ultra Light" cigarettes.
    Shiffman S; Pillitteri JL; Burton SL; Rohay JM; Gitchell JG
    Tob Control; 2001; 10 Suppl 1(Suppl 1):i17-23. PubMed ID: 11740040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescents' beliefs about the risks involved in smoking "light" cigarettes.
    Kropp RY; Halpern-Felsher BL
    Pediatrics; 2004 Oct; 114(4):e445-51. PubMed ID: 15466070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of tar, nicotine, and carbon monoxide yields in the smoke of bidi cigarettes.
    Watson CH; Polzin GM; Calafat AM; Ashley DL
    Nicotine Tob Res; 2003 Oct; 5(5):747-53. PubMed ID: 14577991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy and health implications of using the U.S. Food and Drug Administration product design approach in reducing tobacco product risk.
    Givel M
    Curr Drug Abuse Rev; 2008 Jun; 1(2):135-41. PubMed ID: 19630712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging nicotine delivery products. Implications for public health.
    Benowitz NL
    Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical Determination of Nicotine and Tar Levels in Various Dokha and Shisha Tobacco Products.
    Mahboub B; Mohammad AB; Nahlé A; Vats M; Al Assaf O; Al-Zarooni H
    J Anal Toxicol; 2018 Sep; 42(7):496-502. PubMed ID: 29750269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the yields of tar, nicotine, and carbon monoxide of 36 brands of Canadian cigarettes tested under three conditions.
    Rickert WS; Robinson JC; Young JC; Collishaw NE; Bray DF
    Prev Med; 1983 Sep; 12(5):682-94. PubMed ID: 6657634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing cigarette, 1950-1995.
    Hoffmann D; Hoffmann I
    J Toxicol Environ Health; 1997 Mar; 50(4):307-64. PubMed ID: 9120872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-tar medium-nicotine cigarettes: a new approach to safer smoking.
    Russell MA
    Br Med J; 1976 Jun; 1(6023):1430-3. PubMed ID: 953530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of health messages about "Light" and "Ultra Light" cigarettes on beliefs and quitting intent.
    Shiffman S; Pillitteri JL; Burton SL; Rohay JM; Gitchell JG
    Tob Control; 2001; 10 Suppl 1(Suppl 1):i24-32. PubMed ID: 11740041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications.
    Pederson LL; Nelson DE
    Nicotine Tob Res; 2007 May; 9(5):525-34. PubMed ID: 17454709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four policies to end the sale of cigarettes and smoking tobacco in New Zealand by 2020.
    Laugesen M; Glover M; Fraser T; McCormick R; Scott J
    N Z Med J; 2010 May; 123(1314):55-67. PubMed ID: 20581913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The US tobacco control community's view of the future of tobacco harm reduction.
    Warner KE; Martin EG
    Tob Control; 2003 Dec; 12(4):383-90. PubMed ID: 14660773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.